Arrowstreet Capital, Limited Partnership »

Halozyme Therapeutics shares owned by Arrowstreet Capital, Limited Partnership

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Arrowstreet Capital, Limited Partnership from 13F filings

Historical chart of Arrowstreet Capital, Limited Partnership investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Arrowstreet Capital, Limited Partnership consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Arrowstreet Capital, Limited Partnership

Quarter filed Position value Share count Share price at filing
2024-09-30 $24M 411k 57.24
2024-06-30 $5.4M 103k 52.36
2024-03-31 $281k 6.9k 40.73
2023-09-30 $3.9M 101k 38.20
2022-09-30 $11M 272k 39.54
2022-06-30 $7.0M 159k 44.00
2021-09-30 $17M 416k 40.68
2020-09-30 $1.7M 63k 26.28
2020-06-30 $335k 13k 26.83
2020-03-31 $1.9M 104k 17.99
2019-12-31 $6.8M 386k 17.73
2019-09-30 $1.7M 109k 15.51
2019-03-31 $1.0M 65k 16.09
2018-03-31 $9.4M 482k 19.59
2017-06-30 $131k 10k 12.84